journal article·2025-12Open access

Crystal structure of racemic afoxolaner, C 26 H 17 ClF 9 N 3 O 3

James Kaduk, Anja Dosen, Tom Blanton

Powder Diffraction· Volume 40· Issue 4

Abstract

Abstract The crystal structure of racemic afoxolaner has been solved and refined using synchrotron X-ray powder diffraction data and optimized using density functional theory techniques. Afoxolaner crystallizes in space group P2 1 /a (#14) with a = 9.6014(6), b = 14.0100(11), c = 39.477(10) Å, β = 94.389(7)°, V = 5,294.7(17) Å 3 , and Z = 8 at 298 K. The crystal structure consists of layers of molecules parallel to the ab -plane. The boundaries of the layers are rich in halogens. Within the layers, there is parallel stacking of rings along both the a - and b -axes. Two classical N–H···O hydrogen bonds link the two independent molecules into dimers. The powder pattern has been submitted to the International Centre for Diffraction Data (ICDD ® ) for inclusion in the Powder Diffraction File ™ (PDF ® ).
Source: crossref · Quality: baseline

Research context

OpenAlex topics: X-ray Diffraction in Crystallography · Inorganic Fluorides and Related Compounds · Pigment Synthesis and Properties

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Illinois Institute of Technology

North Central College

International Centre for Diffraction Data (ICDD)

Funding

International Centre for Diffraction Data

References (31)

Show source-provided references
1. 2024
2. 10.1007/BF0054909610.1007/BF00549096 ↗
3. 10.1063/1.46788210.1063/1.467882 ↗
4. 10.1107/S160057752100249610.1107/S1600577521002496 ↗
5. 10.1107/S205252061600395410.1107/S2052520616003954 ↗
6. 2024
7. 10.1107/S002188981300353110.1107/S0021889813003531 ↗
8. 2013
9. 10.1093/nar/gkac95610.1093/nar/gkac956 ↗
10. 2023
11. 10.1021/acs.jctc.2c0095810.1021/acs.jctc.2c00958 ↗
12. 2023
13. 10.1017/S088571561400051710.1017/S0885715614000517 ↗
14. A New Law of Crystal Morphology Extending the Law of Bravais
15. 10.1107/S160057672100291010.1107/S1600576721002910 ↗
16. 10.1107/S160057671901409210.1107/S1600576719014092 ↗
17. Gorter de Vries, R. J. , Ballion, B. , Lafont, S. , de Saint Michel, M. G. , and Kozlovic, S. . 2021. “Crystalline Forms of (S)-Afoxolaner.” U.S. Patent US 11130739 B2.
18. 10.1016/0927-0256(96)00008-010.1016/0927-0256(96)00008-0 ↗
19. 10.1107/S205252061402290210.1107/S2052520614022902 ↗
20. 10.1002/jcc.2315310.1002/jcc.23153 ↗
21. 2023
22. 10.3406/bulmi.1907.282010.3406/bulmi.1907.2820 ↗
23. 10.1017/S088571562400015010.1017/S0885715624000150 ↗
24. 10.1107/S002188989800600110.1107/S0021889898006001 ↗
25. 10.1017/S088571561400090610.1017/S0885715614000906 ↗
26. Bravais · 1866
27. 10.1107/S002188981101462210.1107/S0021889811014622 ↗
28. 10.1107/S002188981301311310.1107/S0021889813013113 ↗
29. 10.1021/ci049780b10.1021/ci049780b ↗
30. Gorter de Vries, R. J. , Ballion, B. , Lafont, S. , de Saint Michel, M. G. , and Kozlovic, S. . 2018. “Crystalline Forms of (S)-Afoxolaner.” U.S. Patent Application 2018/0354917.
31. 10.1017/S088571561800082910.1017/S0885715618000829 ↗